Calidi Biotherapeutics, Inc.
CLDWW- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001855485
No open-market purchases or sales by Calidi Biotherapeutics, Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Other share classesCLDI
13F holders, Q4 2022
Institutional positions in Calidi Biotherapeutics, Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 25
- −2 vs. Q3 2022
- Shares held
- 7.24M
- −847.4K (−10.5%) vs. Q3 2022
- Total value
- $350.0K
- −$130.0K (−27.1%) vs. Q3 2022
- New holders
- 1
- 2 more added
- Sold out
- 3
- 5 more reduced
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CLDWW on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 1 | $1.01K |
| Q3 2024 | 16 | $99.4K |
| Q2 2024 | 17 | $281.5K |
| Q1 2024 | 17 | $385.1K |
| Q4 2023 | 18 | $384.0K |
| Q3 2023 | 22 | $1.64M |
| Q2 2023 | 22 | $866.3K |
| Q1 2023 | 24 | $366.1K |
| Q4 2022 | 25 | $350.0K |
| Q3 2022 | 27 | $479.9K |
| Q2 2022 | 28 | $767.0K |
| Q1 2022 | 29 | $2.83M |
| Q4 2021 | 23 | $3.01M |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Calidi Biotherapeutics, Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Polar Asset Management Partners Inc. | 2,165,086 | $108.3K | 0.00% | 00.0% | Unchanged |
| Nomura Holdings Inc | 467,818 | $53.0K | 0.00% | 00.0% | Unchanged |
| Finepoint Capital LP | 655,200 | $33.0K | 0.01% | 00.0% | Unchanged |
| 683 Capital Management, LLC | 600,000 | $30.0K | 0.00% | 00.0% | Unchanged |
| Shaolin Capital Management LLC | 495,638 | $25.0K | 0.00% | 00.0% | Unchanged |
| Aristeia Capital LLC | 495,000 | $24.8K | 0.00% | 00.0% | Unchanged |
| Highbridge Capital Management LLC | – | $22.0K | 0.00% | – | New |
| Periscope Capital Inc. | 409,800 | $18.8K | 0.00% | +122,400+42.6% | Added |
| Parallax Volatility Advisers, L.P. | 449,286 | $12.4K | 0.00% | −379,522−45.8% | Reduced |
| Cowen and Company, LLC | 107,900 | $5.39K | 0.00% | −50,200−31.8% | Reduced |
| Sona Asset Management (US) LLC | 90,898 | $4.54K | 0.00% | 00.0% | Unchanged |
| Wolverine Asset Management LLC | 84,581 | $4.23K | 0.00% | 00.0% | Unchanged |
| CNH Partners LLC | 49,998 | $2.50K | 0.00% | 00.0% | Unchanged |
| Walleye Capital LLC | 36,469 | $1.82K | 0.00% | 00.0% | Unchanged |
| Prelude Capital Management, LLC | 30,050 | $1.50K | 0.00% | −22,629−43.0% | Reduced |
| Walleye Trading LLC | 20,052 | $1.00K | 0.00% | 00.0% | Unchanged |
| Alpine Global Management, LLC | 18,200 | $1.00K | 0.00% | −41,828−69.7% | Reduced |
| Bank of Montreal | 12,500 | $625 | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 5,000 | $150 | 0.00% | +3,425+217.5% | Added |
| Clear Street LLC | 100 | $0 | 0.00% | 00.0% | Unchanged |
| Arena Investors LP | 333,333 | – | – | 00.0% | Unchanged |
| Ionic Capital Management LLC | 234,913 | – | – | 00.0% | Unchanged |
| EHP Funds Inc. | 187,914 | – | – | −21,038−10.1% | Reduced |
| Radcliffe Capital Management, L.P. | 264,799 | – | – | 00.0% | Unchanged |
| Segantii Capital Management Ltd | 25,000 | – | – | 00.0% | Unchanged |
| Magnetar Financial LLC | 0 | $0 | 0.00% | −435,400−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | – | Sold out |
| Boothbay Fund Management, LLC | 0 | $0 | 0.00% | −22,626−100.0% | Sold out |